LIXT
Price
$1.64
Change
-$0.04 (-2.38%)
Updated
Nov 13 closing price
NTLA
Price
$16.11
Change
-$0.54 (-3.24%)
Updated
Nov 13 closing price
98 days until earnings call
Ad is loading...

LIXT vs NTLA

Header iconLIXT vs NTLA Comparison
Open Charts LIXT vs NTLABanner chart's image
Lixte Biotechnology Holdings
Price$1.64
Change-$0.04 (-2.38%)
Volume$13.82K
CapitalizationN/A
Intellia Therapeutics
Price$16.11
Change-$0.54 (-3.24%)
Volume$2.11M
CapitalizationN/A
LIXT vs NTLA Comparison Chart
Loading...
NTLA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
LIXT vs. NTLA commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LIXT is a Buy and NTLA is a StrongSell.

COMPARISON
Comparison
Nov 14, 2024
Stock price -- (LIXT: $1.65 vs. NTLA: $16.11)
Brand notoriety: LIXT and NTLA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LIXT: 2% vs. NTLA: 93%
Market capitalization -- LIXT: $3.71M vs. NTLA: $1.64B
LIXT [@Biotechnology] is valued at $3.71M. NTLA’s [@Biotechnology] market capitalization is $1.64B. The market cap for tickers in the [@Biotechnology] industry ranges from $473.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.76B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LIXT’s FA Score shows that 0 FA rating(s) are green whileNTLA’s FA Score has 0 green FA rating(s).

  • LIXT’s FA Score: 0 green, 5 red.
  • NTLA’s FA Score: 0 green, 5 red.
According to our system of comparison, NTLA is a better buy in the long-term than LIXT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NTLA’s TA Score shows that 5 TA indicator(s) are bullish.

  • NTLA’s TA Score: 5 bullish, 4 bearish.

Price Growth

LIXT (@Biotechnology) experienced а -8.84% price change this week, while NTLA (@Biotechnology) price change was +0.31% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.97%. For the same industry, the average monthly price growth was +5.49%, and the average quarterly price growth was +6.49%.

Reported Earning Dates

LIXT is expected to report earnings on May 10, 2023.

NTLA is expected to report earnings on Feb 20, 2025.

Industries' Descriptions

@Biotechnology (-1.97% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NTLA($1.64B) has a higher market cap than LIXT($3.71M). LIXT YTD gains are higher at: -29.787 vs. NTLA (-47.163). LIXT has higher annual earnings (EBITDA): -4.01M vs. NTLA (-514.18M). NTLA has more cash in the bank: 691M vs. LIXT (2.6M). LIXT has less debt than NTLA: LIXT (100K) vs NTLA (106M). NTLA has higher revenues than LIXT: NTLA (46M) vs LIXT (0).
LIXTNTLALIXT / NTLA
Capitalization3.71M1.64B0%
EBITDA-4.01M-514.18M1%
Gain YTD-29.787-47.16363%
P/E RatioN/AN/A-
Revenue046M-
Total Cash2.6M691M0%
Total Debt100K106M0%
FUNDAMENTALS RATINGS
LIXT vs NTLA: Fundamental Ratings
LIXT
NTLA
OUTLOOK RATING
1..100
958
VALUATION
overvalued / fair valued / undervalued
1..100
71
Overvalued
35
Fair valued
PROFIT vs RISK RATING
1..100
10094
SMR RATING
1..100
10095
PRICE GROWTH RATING
1..100
8386
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NTLA's Valuation (35) in the Biotechnology industry is somewhat better than the same rating for LIXT (71) in the null industry. This means that NTLA’s stock grew somewhat faster than LIXT’s over the last 12 months.

NTLA's Profit vs Risk Rating (94) in the Biotechnology industry is in the same range as LIXT (100) in the null industry. This means that NTLA’s stock grew similarly to LIXT’s over the last 12 months.

NTLA's SMR Rating (95) in the Biotechnology industry is in the same range as LIXT (100) in the null industry. This means that NTLA’s stock grew similarly to LIXT’s over the last 12 months.

LIXT's Price Growth Rating (83) in the null industry is in the same range as NTLA (86) in the Biotechnology industry. This means that LIXT’s stock grew similarly to NTLA’s over the last 12 months.

LIXT's P/E Growth Rating (100) in the null industry is in the same range as NTLA (100) in the Biotechnology industry. This means that LIXT’s stock grew similarly to NTLA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NTLA
RSI
ODDS (%)
Bullish Trend 1 day ago
78%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
81%
MACD
ODDS (%)
Bullish Trend 1 day ago
73%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
80%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
88%
Advances
ODDS (%)
Bullish Trend 4 days ago
78%
Declines
ODDS (%)
Bearish Trend 1 day ago
86%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
86%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Ad is loading...
NTLA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AREC1.230.12
+10.81%
American Resources Corp
PCSA1.07N/A
N/A
Processa Pharmaceuticals
UNM71.02-0.28
-0.39%
Unum Group
SWBI13.01-0.20
-1.51%
Smith & Wesson Brands
ZETA17.76-10.46
-37.07%
Zeta Global Holdings Corp

LIXT and

Correlation & Price change

A.I.dvisor tells us that LIXT and HSTO have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LIXT and HSTO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LIXT
1D Price
Change %
LIXT100%
-1.79%
HSTO - LIXT
29%
Poorly correlated
N/A
NTLA - LIXT
28%
Poorly correlated
-3.24%
IBIO - LIXT
28%
Poorly correlated
-9.02%
BBIO - LIXT
27%
Poorly correlated
+0.69%
PMN - LIXT
26%
Poorly correlated
N/A
More

NTLA and

Correlation & Price change

A.I.dvisor indicates that over the last year, NTLA has been closely correlated with VCYT. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if NTLA jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NTLA
1D Price
Change %
NTLA100%
-3.24%
VCYT - NTLA
69%
Closely correlated
+3.37%
EDIT - NTLA
68%
Closely correlated
-3.58%
BEAM - NTLA
67%
Closely correlated
-1.57%
CRSP - NTLA
64%
Loosely correlated
-1.85%
DNLI - NTLA
57%
Loosely correlated
-0.84%
More